Bioactivity:

Cevimeline, a parasympathomimetic and muscarinic agonist, affects M1 and M3 receptors. Cevimeline has been shown to treat dry mouth and Sjﾚgren's syndrome. It is also used to reduce Xerostomia symptoms and increase salivary flow in head and neck cancer su

CAS nr:

107233-08-9

Purity:

98%

Molecular Weight:

199,31

SMILES:

C[C@H]1O[C@]2(CS1)CN3CCC2CC3

Formula:

C10H17NOS

Pathway:

Target: